-
1
-
-
0025257248
-
Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: Experience of the Non-Hodgkin's Lymphoma Pathologic Classification Project
-
Simon R, Durrleman S, Hoppe RT, et al. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the Non-Hodgkin's Lymphoma Pathologic Classification Project. Med Pediatr Oncol. 1990;18:89-96.
-
(1990)
Med Pediatr Oncol
, vol.18
, pp. 89-96
-
-
Simon, R.1
Durrleman, S.2
Hoppe, R.T.3
-
2
-
-
0027444652
-
A predictive model for aggressive non-Hodgkin's lymphoma
-
The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
-
(1993)
N Engl J Med
, vol.329
, pp. 987-994
-
-
-
3
-
-
31644438274
-
Interim analysis of LSG-4 protocol study on the treatment of aggressive non-Hodgkin's lymphomas in Japan
-
Kimura K, Yamada K, Carter SK, Longo DL, eds. New York, NY: Elsevier Science
-
Fukuhara S, Shimoyama M, Minato K, et al. Interim analysis of LSG-4 protocol study on the treatment of aggressive non-Hodgkin's lymphomas in Japan. In: Kimura K, Yamada K, Carter SK, Longo DL, eds. Cancer Chemotherapy: Challenges for the Future. Proceedings of the Eighth Nagoya International Symposium on Cancer Treatment, Nagoya, Japan, 16-17 October 1992. New York, NY: Elsevier Science: 1993;8:289-294.
-
(1993)
Cancer Chemotherapy: Challenges for the Future. Proceedings of the Eighth Nagoya International Symposium on Cancer Treatment, Nagoya, Japan, 16-17 October 1992
, vol.8
, pp. 289-294
-
-
Fukuhara, S.1
Shimoyama, M.2
Minato, K.3
-
4
-
-
31644446480
-
Recent topics in the treatment of aggressive lymphoma in Japan
-
Kimura K, Ota K, Yamada K, Saito H, Ogawa M. eds. New York, NY: Elsevier Science
-
Kobayashi T, Shimoyama M, Shirakawa S, et al. Recent topics in the treatment of aggressive lymphoma in Japan. In: Kimura K, Ota K, Yamada K, Saito H, Ogawa M. eds. Cancer Chemotherapy: Challenges for the Future. Proceedings of the Tenth International Symposium on Cancer Treatment, Nagoya, Japan, 16-17 September 1994. New York, NY: Elsevier Science; 1995;10:92-100.
-
(1995)
Cancer Chemotherapy: Challenges for the Future. Proceedings of the Tenth International Symposium on Cancer Treatment, Nagoya, Japan, 16-17 September 1994
, vol.10
, pp. 92-100
-
-
Kobayashi, T.1
Shimoyama, M.2
Shirakawa, S.3
-
5
-
-
9444287115
-
A randomized controlled trial investigating the survival benefit of close-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002
-
Kinoshita T, Hotta T, Tobinai K, et al. A randomized controlled trial investigating the survival benefit of close-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002. Int J Hematol. 2004;80:341-350.
-
(2004)
Int J Hematol
, vol.80
, pp. 341-350
-
-
Kinoshita, T.1
Hotta, T.2
Tobinai, K.3
-
6
-
-
0023102508
-
Agreement rates and American-Japanese pathologists' comparability of a modified Working Formulation for non-Hodgkin's lymphomas: An analysis of the cases collected for the Fifth International Workshop on Chromosomes in Leukemia-Lymphoma
-
Nanba K, Yamamoto H, Kamada N, et al. Agreement rates and American-Japanese pathologists' comparability of a modified Working Formulation for non-Hodgkin's lymphomas: an analysis of the cases collected for the Fifth International Workshop on Chromosomes in Leukemia-Lymphoma. Cancer. 1987;59: 1463-1469.
-
(1987)
Cancer
, vol.59
, pp. 1463-1469
-
-
Nanba, K.1
Yamamoto, H.2
Kamada, N.3
-
7
-
-
0019866936
-
A new histological classification of malignant lymphomas (LSG classification) and its significance
-
Mikata A. A new histological classification of malignant lymphomas (LSG classification) and its significance. Nippon Ketsueki Gakkai Zasshi. 1981;44:1401-1410.
-
(1981)
Nippon Ketsueki Gakkai Zasshi
, vol.44
, pp. 1401-1410
-
-
Mikata, A.1
-
8
-
-
0018605304
-
Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma: A proposal of a new type
-
Suchi T, Tajima K, Nanba K, et al. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma: a proposal of a new type. Acta Pathol Jpn. 1979;29:755-776.
-
(1979)
Acta Pathol Jpn
, vol.29
, pp. 755-776
-
-
Suchi, T.1
Tajima, K.2
Nanba, K.3
-
9
-
-
17444454475
-
Toxicity grading criteria of the Japan Clinical Oncology Group: The Clinical Trial Review Committee of the Japan Clinical Oncology Group
-
Tobinai K, Kohno A, Shimada Y, et al. Toxicity grading criteria of the Japan Clinical Oncology Group: the Clinical Trial Review Committee of the Japan Clinical Oncology Group. Jpn J Clin Oncol. 1993;23:250-257.
-
(1993)
Jpn J Clin Oncol
, vol.23
, pp. 250-257
-
-
Tobinai, K.1
Kohno, A.2
Shimada, Y.3
-
10
-
-
0003486931
-
-
Geneva, Switzerland: World Health Organization; WHO offset publication No. 48
-
World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization; 1979. WHO offset publication No. 48.
-
(1979)
WHO Handbook for Reporting Results of Cancer Treatment
-
-
-
11
-
-
0018866647
-
Sample size considerations for non-randomized comparative studies
-
Makuch RW, Simon RM. Sample size considerations for non-randomized comparative studies. J Chronic Dis. 1980;33:175-181.
-
(1980)
J Chronic Dis
, vol.33
, pp. 175-181
-
-
Makuch, R.W.1
Simon, R.M.2
-
13
-
-
0025277237
-
Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: A feasibility study using a mitoxantrone containing regimen
-
Sonneveld P, Michiels JJ. Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen. Br J Cancer. 1990;62:105-108.
-
(1990)
Br J Cancer
, vol.62
, pp. 105-108
-
-
Sonneveld, P.1
Michiels, J.J.2
-
14
-
-
0025865531
-
Low-dose ACOP-B and VABE: Weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma
-
O'Reilly SE, Klimo P, Connors JM. Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma. J Clin Oncol. 1991;9:741-747.
-
(1991)
J Clin Oncol
, vol.9
, pp. 741-747
-
-
O'Reilly, S.E.1
Klimo, P.2
Connors, J.M.3
-
15
-
-
0027394689
-
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
-
Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993;328: 1002-1006.
-
(1993)
N Engl J Med
, vol.328
, pp. 1002-1006
-
-
Fisher, R.I.1
Gaynor, E.R.2
Dahlberg, S.3
-
16
-
-
20344362405
-
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma
-
Mori M, Kitamura K, Masuda M, et al. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma. Int J Hematol. 2005;81:246-254.
-
(2005)
Int J Hematol
, vol.81
, pp. 246-254
-
-
Mori, M.1
Kitamura, K.2
Masuda, M.3
-
17
-
-
0004815869
-
CHOP is the standard regimen in patients ≥70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
-
Tirelli U, Errante D, van Glabbeke M. et al. CHOP is the standard regimen in patients ≥70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol. 1998;16:27-34.
-
(1998)
J Clin Oncol
, vol.16
, pp. 27-34
-
-
Tirelli, U.1
Errante, D.2
Van Glabbeke, M.3
-
18
-
-
0034985710
-
Reduced-dose CHOP therapy for elderly patients with non-Hodgkin's lymphoma
-
Mori M, Niitsu N, Takagi T, et al. Reduced-dose CHOP therapy for elderly patients with non-Hodgkin's lymphoma. Leuk Lymphoma. 2001;41:359-366.
-
(2001)
Leuk Lymphoma
, vol.41
, pp. 359-366
-
-
Mori, M.1
Niitsu, N.2
Takagi, T.3
-
19
-
-
0037165261
-
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
-
Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235-242.
-
(2002)
N Engl J Med
, vol.346
, pp. 235-242
-
-
Coiffier, B.1
Lepage, E.2
Briere, J.3
-
20
-
-
0037295169
-
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma
-
Bessell EM, Burton A, Haynes AP, et al. A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma. Ann Oncol. 2003;14:258-267.
-
(2003)
Ann Oncol
, vol.14
, pp. 258-267
-
-
Bessell, E.M.1
Burton, A.2
Haynes, A.P.3
-
21
-
-
0038603184
-
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: Results of a Nordic Lymphoma Group randomized trial
-
Osby E, Hagberg H, Kvaloy S, et al. CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood. 2003;101:3840-3848.
-
(2003)
Blood
, vol.101
, pp. 3840-3848
-
-
Osby, E.1
Hagberg, H.2
Kvaloy, S.3
-
22
-
-
0042914721
-
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma
-
Doorduijn JK, van der Halt B, van Imhoff GW, et al. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2003;21:3041-3050.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3041-3050
-
-
Doorduijn, J.K.1
Van Der Halt, B.2
Van Imhoff, G.W.3
-
23
-
-
3242802160
-
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: Results of the NHL-B2 trial of the DSHNHL
-
Pfreundschuh M, Trumper L, Kloess M, et al, and the German High-Grade Non-Hodgkin's Lymphoma Study Group. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood. 2004;104:634-641.
-
(2004)
Blood
, vol.104
, pp. 634-641
-
-
Pfreundschuh, M.1
Trumper, L.2
Kloess, M.3
-
24
-
-
0033168330
-
Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients
-
Zinzani PL, Storti S, Zaccaria A, et al. Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients. Blood. 1999;94:33-38.
-
(1999)
Blood
, vol.94
, pp. 33-38
-
-
Zinzani, P.L.1
Storti, S.2
Zaccaria, A.3
-
25
-
-
10744224285
-
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
-
Tilly H, Lepage E, Coiffier B, et al. Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. Blood. 2003; 102:4284-4289.
-
(2003)
Blood
, vol.102
, pp. 4284-4289
-
-
Tilly, H.1
Lepage, E.2
Coiffier, B.3
-
27
-
-
20444500958
-
A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: Prognostic impact independent of International Prognostic Index
-
Janssen-Heijnen, van Spronsen DJ, Lemmens VE, Houterman S, Verheij KD, Coebergh JW. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index. Br J Haematol. 2005;129:597-606.
-
(2005)
Br J Haematol
, vol.129
, pp. 597-606
-
-
Janssen-Heijnen1
Van Spronsen, D.J.2
Lemmens, V.E.3
Houterman, S.4
Verheij, K.D.5
Coebergh, J.W.6
-
28
-
-
0345490987
-
Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: Systematic review and meta-analysis
-
Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723-1732.
-
(2003)
Gastroenterology
, vol.125
, pp. 1723-1732
-
-
Gisbert, J.P.1
Garcia-Buey, L.2
Pajares, J.M.3
Moreno-Otero, R.4
-
29
-
-
10744224509
-
Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: A Japan Clinical Oncology Group Study, JCOG9301
-
Takenaka T, Ho K, Suzuki T, et al. Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan Clinical Oncology Group Study, JCOG9301. Int J Hematol. 2004;79:165-173.
-
(2004)
Int J Hematol
, vol.79
, pp. 165-173
-
-
Takenaka, T.1
Ho, K.2
Suzuki, T.3
-
30
-
-
0030067985
-
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus
-
Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet. 1996;347:92-93.
-
(1996)
Lancet
, vol.347
, pp. 92-93
-
-
Vento, S.1
Cainelli, F.2
Mirandola, F.3
-
31
-
-
0032530425
-
Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies
-
Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer. 1998;83: 1224-1230.
-
(1998)
Cancer
, vol.83
, pp. 1224-1230
-
-
Zuckerman, E.1
Zuckerman, T.2
Douer, D.3
Qian, D.4
Levine, A.M.5
-
32
-
-
0032719594
-
Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy: A prospective study in 305 patients
-
Markovic S, Drozina G, Vovk M, Fidler-Jenko M. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy: a prospective study in 305 patients. Hepatogastroenterology. 1999;46:2925-2930.
-
(1999)
Hepatogastroenterology
, vol.46
, pp. 2925-2930
-
-
Markovic, S.1
Drozina, G.2
Vovk, M.3
Fidler-Jenko, M.4
|